Keywords: trophos, initiates, pivotal, efficacy, study, als, drug

Trophos initiates pivotal efficacy study of ALS drug

Article | 06 May 2009

Print This

French drug developer Trophos SA has initiated a pivotal efficacy study of olesoxime in amyotrophic lateral sclerosis. The study is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in